This Article Full Text Full Text (PDF) A correction has been published Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maalouf, N. M. Articles by Shane, E. Search for Related Content PubMed PubMed Citation Articles by Maalouf, N. M. Articles by Shane, E. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Organ Transplantation Osteoporosis Hazardous Substances DB PARATHYROID HORMONE Related Collections Calcium and Bone Metabolism

Osteoporosis after Solid Organ Transplantation

Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center (N.M.M.), Dallas, Texas 75390; and Department of Medicine, Columbia-Presbyterian Medical Center and College of Physicians and Surgeons, Columbia University (E.S.), New York, New York 10032

Address all correspondence and requests for reprints to: Dr. Elizabeth Shane, Department of Medicine, College of Physicians and Surgeons, Columbia University, PH8–864, 630 West 168th Street, New York, New York 10032. E-mail: es54{at}columbia.edu.

With the rapid increase in the number of organs transplanted worldwide and the improved survival of transplant recipients, osteoporosis has emerged as a frequent complication of the transplantation process. In the past decade, the wider recognition of transplantation-related osteoporosis has led to a decrease in the risk of fracture for the individual patient. Nonetheless, fracture rates remain unacceptably high in transplant recipients. This presentation reviews the epidemiology of transplantation-related osteoporosis, the factors contributing to the pathogenesis of this complication, and the evaluation, prevention, and treatment options available for kidney, liver, lung, and heart transplant recipients.

This article has been cited by other articles:

				D. M. Lyu and M. R. Zamora Medical Complications of Lung Transplantation Proceedings of the ATS, January 15, 2009; 6(1): 101 - 107. [Abstract] [Full Text] [PDF]

				P. Evenepoel, B. K.I. Meijers, H. de Jonge, M. Naesens, B. Bammens, K. Claes, D. Kuypers, and Y. Vanrenterghem Recovery of Hyperphosphatoninism and Renal Phosphorus Wasting One Year after Successful Renal Transplantation Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1829 - 1836. [Abstract] [Full Text] [PDF]

				J. Cunningham Pathogenesis and Prevention of Bone Loss in Patients Who Have Kidney Disease and Receive Long-Term Immunosuppression J. Am. Soc. Nephrol., January 1, 2007; 18(1): 223 - 234. [Abstract] [Full Text] [PDF]

				A. Djamali, M. Samaniego, B. Muth, R. Muehrer, R. M. Hofmann, J. Pirsch, A. Howard, G. Mourad, and B. N. Becker Medical Care of Kidney Transplant Recipients after the First Posttransplant Year Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 623 - 640. [Abstract] [Full Text] [PDF]

				O. Tschopp, C. Schmid, R. Speich, B. Seifert, E. W. Russi, and A. Boehler Pretransplantation bone disease in patients with primary pulmonary hypertension. Chest, April 1, 2006; 129(4): 1002 - 1008. [Abstract] [Full Text] [PDF]

				L. G. Raisz Screening for Osteoporosis N. Engl. J. Med., July 14, 2005; 353(2): 164 - 171. [Full Text] [PDF]